Longevity Biotech Company is L’Oréal’s new investment 2024
L’Oréal announced on Tuesday that it has acquired a minority stake in Timeline, a Swiss biotech company that specializes in longevity.
The venture capital fund of L’Oréal, BOLD, has announced the investment in Timeline, a Swiss longevity biotech company
The Swiss consumer health startup Timeline has received funding from BOLD (Business Opportunities for L’Oréal Development), the venture capital arm of the L’Oréal Groupe, which made the announcement on Tuesday.
Nestlé participated in the $66 million Series D round led by BOLD.
Timeline was founded in 2007 and uses patented technology called Mitopure, which is integrated into its range of topical skincare products and supplements, to focus on aging and longevity. The company plans to expand into the food, beauty, and health sectors with the proceeds from its most recent funding round.
Barbara Lavernos, Deputy Chief Executive Officer and in charge of Research, Innovation and Technology, L’Oréal Groupe, said:
“Longevity is about living healthier for longer and L’Oréal has been working for more than a decade to understand and anticipate what this could mean for beauty. Longevity adds a new dimension to beauty, focused on predicting, correcting and even reversing the ageing of our skin, scalp and hair. Our investment in Timeline is exciting for its potential to transpose key hallmarks of longevity onto skin health and beauty.”
Patrick Aebischer, Co-Founder and Chairman of Timeline, also commented:
“This strategic collaboration reflects the breakthrough multidimensional approach that we’ve always believed is necessary to make meaningful advancements for longevity and healthspan. I want to thank L’Oréal for its commitment to longevity solutions rooted in the highest level of science.”
Longevity biotech is already becoming more popular in the beauty industry and is receiving increased attention in the health and scientific domains. Estée Lauder unveiled a new skin longevity platform in December 2023 along with the release of their most recent face cream, Re-Nutriv, which includes an ingredient developed through research. Longevity beauty startups like OneSkin and Aramore—a company started by President John F. Kennedy Jr.’s nephew Stephen Kennedy Smith—have entered the market in addition to conglomerates.
L’Oréal in a statement on Tuesday:
“Timeline has developed a proprietary molecule, Mitopure, that recycles and rejuvenates aging mitochondria, the powerhouses of cells. This breakthrough technology is backed by more than a decade of research by distinguished scientists, multiple gold standard clinical studies and an unparalleled intellectual property portfolio. The investment will enable Timeline to further develop its unique technology and expand operations, while enabling future collaboration with L’Oréal.”
The vocabulary and emphasis of the beauty industry never stop growing. Recently, the terms “health” and “well-being” have become popular. Now that those two are convergent along with scientific advancements, longevity is emerging as a major topic of conversation and a market influencer.
BOLD has been accelerating the rate of acquisitions. The acquisition of environmental water technology start-up Gjosa was disclosed on January 9. Shinehigh Innovation and Genomatica Inc., a project focused on creating, manufacturing, and marketing biotech based substitutes for important ingredients in beauty products, were among the investments made by the venture capital fund last year.
Concerning L’Oréal
L’Oréal, the largest player in the beauty industry, has dedicated itself exclusively to meeting the aspirations of consumers worldwide for beauty for more than 110 years. Their goal is to produce beauty that inspires people around the world, which characterizes our aesthetic as inclusive, moral, giving, and dedicated to the sustainability of the environment and society.
They offer everyone in the world the best in terms of quality, efficacy, safety, sincerity, and responsibility through their extensive portfolio of 37 global brands and their audacious sustainability commitments in their L’Oréal for the Future program. They also celebrate beauty in its infinite plurality.
The Group produced sales of 38.26 billion euros in 2022 with 87 400 dedicated employees, a balanced geographic footprint, and sales across all distribution networks (e-commerce, mass market, department stores, pharmacies, hair salons, branded, and travel retail). L’Oréal is committed to creating the future of beauty and emerging as a leader in the Beauty Tech industry.
With 20 research centers spread across 11 countries and a dedicated Research and Innovation team comprising over 4,000 scientists and 5,500 tech and digital professionals, the company is focused on this goal.
About BOLD
L’Oréal’s global corporate venture capital fund is called BOLD, or Business Opportunities for L’Oréal Development. By making strategic minority investments in promising startups throughout the beauty value chain, BOLD has, since its founding in 2018, explored the frontier of beauty. Its investment portfolio comprises cutting-edge businesses in the biotech and technology sectors in addition to up-and-coming brands.
Regarding Timeline
With its ground-breaking, clinically validated, proprietary ingredient Mitopure®, Timeline (parent company Amazentis) is a trailblazing Swiss health science company dedicated to revolutionizing the longevity industry. Timeline integrates Mitopure’s benefits into its next-generation nutritional supplements and topical skin health products, providing a comprehensive approach to cellular health.
Timeline, which has more than ten years of experience in aging science research, aims to extend human health and contribute to a time when everyone can live longer, healthier lives. The company has more than 50 patents, several clinical studies, more than 15 years of research by eminent scientists, and Nestlé Health Science has been an investor since 2019.
Conclusion: L’Oréal acquired a minority stake in Timeline, a Swiss biotech company, in order to provide longevity to their clients through their products.
Read more:
NEWSLETTER
Vuoi ricevere Mam-e direttamente nella tua casella di posta? Iscriviti alla Newsletter, ti manderemo un’email a settimana con il meglio del nostro Magazine.
